In a recent White Coat Investor article titled “Malpractice Tail Coverage in the Age of Nuclear Verdicts,” MEDPLI CEO Max Schloemann shares why tail coverage is more important than ever in 2026.
-
MEDPLI CEO Max Schloemann offers expert strategies for budgeting tail insurance in retirement in White Coat Investor. Read more here.
-
MEDPLI was quoted in an article on claims-made vs. occurrence malpractice insurance in White Coat Investor on tail. See here.
Max Schloemann, founder of MEDPLI, was published in a [...]
Max Schloemann, founder of MEDPLI, was featured by Property [...]
Max Schloemann, founder of MEDPLI, had an article published [...]
-
Max Schloemann, independent medical malpractice insurance broker and founder [...]
Max Schloemann, Founder and CEO of MEDPLI, was recently [...]
-
Max Schloemann, Founder and CEO of MEDPLI, was recently [...]
